*Completed research projects are marked with a black line.
The early diagnosis and subtype classification of Alzheimer's disease based on digitalized speech signal
Development and clinical application of digital therapeutic devices UX, untact clinical cloud platforms and RWE technologies based on the brain and body of the elderly
Discovery of effective bacterial strains regulating the inflammatory response of microglia and identification of underlying mechanism through intestinal microbiome analysis of Alzheimer’s disease patients
Study of dementia specific Microbiome, lipidome and microRNA profile
한국형 치매(K-dementia) 통합 빅데이터 허브 시스템 구축
To evaluate the safety and efficacy of PM012 tablets for Alzheimer’s disease, dose-finding study will be performed on phase 2b, and the established dose will be used for the non-inferiority phase 3 trial to evaluate the investigational product’s safety and efficacy: Double blind, randomized, active drug comparative, multi-center, parallel-group clinical trial
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer’s disease (K-BASE)
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer’s disease 2 (K-BASE2)
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase IV Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With degenerative Mild Cognitive Impairment
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer’s Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects with Early Alzheimer’s Disease
Korean Registry for Activating Trial on Dementia (KReAT-D)
Post-market surveillance study of the Neurofolio
The Effects of COVID-19 Quarantine on the Cognitive and Behavioral Symptoms of Dementia
대기오염과 알츠하이머병의 관계 규명 연구
Developing mirroring expression based interactive robot technique by non-contact sensing and recognizing human intrinsic parameter for emotion healing through heart-body feedback
20년 AI 음성 선별 모델 개발을 위한 음성기반 조기 치매선별 연구용역
Emotional recovery of patients with patients using facial emotional feedback program using camera
Standardization of neuropsychological test for dementia classification
Verification of the Effects of Intervention Program on Improving Mental Health of patients with Post-traumatic Stress Disorder
A phase III, multicenter, randomized, double blind, placebo controlled, parallel group, efficacy and safety study of crenezumab in patients with prodromal to mild alzheimer’s disease
Post-market surveillance study of the Neurofolio
The Effects of COVID-19 Quarantine on the Cognitive and Behavioral Symptoms of Dementia
대기오염과 알츠하이머병의 관계 규명 연구
The early diagnosis and subtype classification of Alzheimer's disease based on digitalized speech signal
Development and clinical application of digital therapeutic devices UX, untact clinical cloud platforms and RWE technologies based on the brain and body of the elderly
Developing mirroring expression based interactive robot technique by non-contact sensing and recognizing human intrinsic parameter for emotion healing through heart-body feedback
20년 AI 음성 선별 모델 개발을 위한 음성기반 조기 치매선별 연구용역
Emotional recovery of patients with patients using facial emotional feedback program using camera
Standardization of neuropsychological test for dementia classification
Verification of the Effects of Intervention Program on Improving Mental Health of patients with Post-traumatic Stress Disorder
Discovery of effective bacterial strains regulating the inflammatory response of microglia and identification of underlying mechanism through intestinal microbiome analysis of Alzheimer’s disease patients
Study of dementia specific Microbiome, lipidome and microRNA profile
한국형 치매(K-dementia) 통합 빅데이터 허브 시스템 구축
To evaluate the safety and efficacy of PM012 tablets for Alzheimer’s disease, dose-finding study will be performed on phase 2b, and the established dose will be used for the non-inferiority phase 3 trial to evaluate the investigational product’s safety and efficacy: Double blind, randomized, active drug comparative, multi-center, parallel-group clinical trial
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer’s disease (K-BASE)
Korean Brain Aging Study for Early Diagnosis and Prediction of Alzheimer’s disease 2 (K-BASE2)
A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase IV Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With degenerative Mild Cognitive Impairment
A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month Study With an Open-Label Extension Phase to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer’s Disease
A Placebo-Controlled, Double-Blind, Parallel-Group, 24-Month Study to Evaluate the Efficacy and Safety of E2609 in Subjects with Early Alzheimer’s Disease
Korean Registry for Activating Trial on Dementia (KReAT-D)
A phase III, multicenter, randomized, double blind, placebo controlled, parallel group, efficacy and safety study of crenezumab in patients with prodromal to mild alzheimer’s disease
